Omnicell Inc (STU:OC9)
€ 30.6 -1.4 (-4.38%) Market Cap: 1.40 Bil Enterprise Value: 1.31 Bil PE Ratio: 42.11 PB Ratio: 1.25 GF Score: 75/100

Omnicell Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 07:20PM GMT
Release Date Price: €35.2 (-3.30%)
David Roman
Goldman Sachs - Analyst

Well, good afternoon, everyone. I'd like to welcome everyone here to a presentation from Omnicell. Very pleased to have the management team here today. Thank you for making the trip.

You probably don't know this, but when I spent about five years at Baxter, so I got very familiar with the pharmacy space. And while we don't cover Omnicell, I've always sort of seen the company in out and about doing customer visits and also just doing kind of the general market research. So really pleased to have the opportunity to sit down with you and talk a little bit about the business.

Randall Lipps
Omnicell Inc - Chairman of the Board, President, Chief Executive Officer

Well, glad to be here, Dave. Thanks for having us.

Questions & Answers

David Roman
Goldman Sachs - Analyst

So maybe we just sort of start with some like high-level framing here. I mean, you've come out of a tough period for the business, and now you're seeing growth kind of reaccelerate here. Maybe just

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot